EU Parallel Trade: The ‘Most Effective Savings Tool Available’
Rebranded Group Claims Practice Also Helps Reduce Shortages
The EU association representing parallel traders says cheaper parallel imports are vital in keeping medicines affordable for member states.
You may also be interested in...
The UK government has drawn up a list of 24 medicines that must not be parallel exported to EU countries. The move is widely seen as a way of protecting stockpiles of drugs that have been built up to compensate for supply chain problems in the event of a no-deal Brexit.
As part of its efforts to preserve patient access to medicines amid the COVID-19 pandemic, Russia is planning to cap drug prices if increases of more than 30% are detected. It will also allow online sales of non-prescription drugs and may also tighten the rules on fake and substandard products.
France is exploring the use of hydroxychloroquine and lopinavir/ritonavir in COVID-19, but only in hospitalized patients and in clinical trials, and has banned all exports of the products to avoid possible shortages.